Inflectra and Neuralgia - a phase IV clinical study of FDA data


Neuralgia is found among people who take Inflectra, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Inflectra and have Neuralgia. It is created by eHealthMe based on reports of 26,918 people who have side effects when taking Inflectra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

26,918 people reported to have side effects when taking Inflectra.
Among them, 39 people (0.14%) have Neuralgia.

What is Inflectra?

Inflectra has active ingredients of infliximab-dyyb. eHealthMe is studying from 26,943 Inflectra users for its effectiveness, alternative drugs and more.

What is Neuralgia?

Neuralgia (pain in one or more nerves) is found to be associated with 2,172 drugs and 1,646 conditions by eHealthMe.

Number of Inflectra and Neuralgia reports submitted per year:

Could Inflectra cause Neuralgia?

Time on Inflectra when people have Neuralgia *:

  • < 1 month: 58.33 %
  • 1 - 6 months: 41.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Neuralgia when taking Inflectra *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Neuralgia when taking Inflectra *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Inflectra *:

  1. Imuran: 14 people, 35.90%
  2. Acetaminophen: 10 people, 25.64%
  3. Tylenol: 10 people, 25.64%
  4. Benadryl: 7 people, 17.95%
  5. Morphine: 4 people, 10.26%
  6. Lipitor: 4 people, 10.26%
  7. Pentasa: 4 people, 10.26%
  8. Flagyl: 3 people, 7.69%
  9. Methotrexate: 3 people, 7.69%
  10. Hydrocortisone: 3 people, 7.69%

Common side effects people have besides Neuralgia *:

  1. Joint Pain: 15 people, 38.46%
  2. Herpes Zoster: 12 people, 30.77%
  3. Blood Pressure Fluctuation: 12 people, 30.77%
  4. Malaise (a feeling of general discomfort or uneasiness): 11 people, 28.21%
  5. Drug Ineffective: 11 people, 28.21%
  6. Weight Increased: 10 people, 25.64%
  7. High Blood Pressure: 9 people, 23.08%
  8. Night Sweats (sweating in night): 9 people, 23.08%
  9. Chills (felling of cold): 9 people, 23.08%
  10. Poor Venous Access: 8 people, 20.51%

Common conditions people have *:

  1. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 20 people, 51.28%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 25.64%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 15.38%
  4. Sleep Disorder: 2 people, 5.13%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.13%
  6. Pain: 2 people, 5.13%
  7. Joint Pain: 2 people, 5.13%
  8. Irritable Bowel Syndrome: 2 people, 5.13%
  9. Infection: 2 people, 5.13%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Inflectra and have Neuralgia?

Check whether Neuralgia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Neuralgia and when was it recovered:

Expand to all the drugs that have ingredients of infliximab-dyyb:

Alternative drugs to, pros and cons of Inflectra:

Common Inflectra side effects:

Browse all side effects of Inflectra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Neuralgia treatments and more:

COVID vaccines that are related to Neuralgia:

Common drugs associated with Neuralgia:

All the drugs that are associated with Neuralgia:

Common conditions associated with Neuralgia:

All the conditions that are associated with Neuralgia:

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-dyyb (the active ingredients of Inflectra) and Inflectra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: